With enough 'organs on a chip' a sort of 'body on a chip' may one day soon be available for testing of drugs, the Economist reports.
Registering provides access to this and other free content.
Already have an account?Login Now.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.